Happy lung Insightful Heart High quality

Why Invest in Electromed
  • Large, expanding bronchiectasis market supported by industry tailwinds
  • Clinically proven therapy
  • Well established reimbursement code with broad payer coverage
  • Consistent double-digit organic revenue growth
  • History of high gross margins, robust operating cash flow and increased operating leverage
  • Attractive valuation at 1.8x EV/Revenue

Corporate Strategy

  • Continued sales force expansion along with complementary infrastructure investments
  • Direct-to-consumer and physician marketing to increase brand awareness and revenue
  • Best-in-class customer care and support
  • Develop and promulgate the body of bronchiectasis clinical evidence to increase physician adoption of the SmartVest® System for patients
  • Promote the best-in-class SmartVest Clearway® device

Vision: Improve quality of life for a greater number of patients with compromised pulmonary function and reduce overall healthcare utilization through therapy with SmartVest® Airway Clearance System.